Liver treatment with an adenovirus expressing Dyrk1A normalizes hepatic DYRK1A level and decreases hyperhomocysteinemia in mice with hyperhomocysteinemia. The gene discussed is DYRK1A; the disease is hyperhomocysteinemia.